Product
Enteric-Coated Mycophenolate
1 clinical trial
2 indications
Indication
Liver Transplant RejectionIndication
Adverse Reaction to ImmunosuppressantsClinical trial
Clinical Evaluation of the Long-term Benefit of Enteric-coated Mycophenolate (MPAs) After Liver TransplantationStatus: Recruiting, Estimated PCD: 2023-06-30